Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Takebayashi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Takebayashi, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 630-636
© 2002 European Renal Association-European Dialysis and Transplant Association

Possible involvement of increased glycoxidation and lipid peroxidation of elastin in atherogenesis in haemodialysis patients

Yuji Yamamoto1,2, Noriyuki Sakata1,, Jing Meng1, Masaya Sakamoto2, Akiko Noma2, Iori Maeda2, Kouji Okamoto2 and Shigeo Takebayashi1

1 Second Department of Pathology, School of Medicine, Fukuoka University, Fukuoka, Japan and 2 Department of Biochemical Engineering and Science, Kyushu Institute of Technology, Iizuka, Japan

Background. Glycoxidation and lipid peroxidation products accumulate in collagen of various tissues in haemodialysis patients with end-stage renal disease (ESRD). The purpose of this study was to test the hypothesis that increased glycoxidation and lipid peroxidation of aortic elastin is implicated in the cardiovascular complications, particularly atherosclerosis, of chronic haemodialysis patients.

Methods. Post-mortem aortic samples were obtained from 16 deceased subjects, including chronic haemodialysis patients (group 1 n=6, age 64.7±11.4 years) and control subjects (group 2 n=10, age 61.1±10.4 years). The samples were divided into three vessel wall sites: atherosclerotic intima, lesion-free intima, and media. They were sequentially treated with 0.01 M phosphate-buffered saline, collagenase, and elastase to obtain three fractions, namely soluble (SF), collagen (CF), and elastin (EF) fractions, respectively. Using spectrophotofluorometry, the pentosidine- and malondialdehyde (MDA)-linked fluorescence of these fractions was measured at wavelengths 335/385 and 390/460 (excitation/emission), respectively.

Results. Samples from haemodialysis patients (group 1) exhibited a significant increase in both pentosidine- and MDA-linked fluorescence of EF in atherosclerotic intima, lesion-free intima, and media samples, compared with samples from control subjects (group 2). In group 1, the levels of pentosidine- and MDA-linked fluorescence of EF were highest in atherosclerotic intima among the three aortic sites. Interestingly, in both groups, the levels of pentosidine- and MDA-linked fluorescence of EF were significantly higher than those of CF in all aortic sites. There was a strong correlation between the levels of pentosidine- and MDA-linked fluorescence in CF and EF for all aortic sites. In group 1, the pentosidine- and MDA-linked fluorescence levels of EF correlated significantly with the duration of haemodialysis in lesion-free intima and media.

Conclusions. Our study provides the first biochemical evidence for a close link between aortic elastin glycoxidation and lipid peroxidation. In addition, we demonstrated high levels of these products in the aortic elastin of haemodialysis patients with ESRD. Our findings support the hypothesis that modification of aortic elastin by glycoxidation and lipid peroxidation may contribute to the development of vascular complications, particularly atherosclerosis, in patients with end-stage renal failure.

Keywords: cardiovascular complications; elastin; end-stage renal disease; glycoxidation; haemodialysis; lipid peroxidation

Correspondence and offprint requests to: Noriyuki Sakata, MD, Second Department of Pathology, School of Medicine Fukuoka University 45-1, 7-chome Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan. Email: nysakata{at}fukuoka\|[hyphen]\|u.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
G. Schillaci, M. Pirro, M. R. Mannarino, G. Pucci, G. Savarese, S. S. Franklin, and E. Mannarino
Relation Between Renal Function Within the Normal Range and Central and Peripheral Arterial Stiffness in Hypertension
Hypertension, October 1, 2006; 48(4): 616 - 621.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Sakata, A. Noma, Y. Yamamoto, K. Okamoto, J. Meng, S. Takebayashi, R. Nagai, and S. Horiuchi
Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease
Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1601 - 1609.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Sakata, A. Noma, Y. Yamamoto, K. Okamoto, J. Meng, S. Takebayashi, R. Nagai, and S. Horiuchi
Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease
Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1601 - 1609.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.